ALYFTREO Trademark

Trademark Overview

On Wednesday, May 16, 2018, a trademark application was filed for ALYFTREO with the United States Patent and Trademark Office. The USPTO has given the ALYFTREO trademark a serial number of 87924232. The federal status of this trademark filing is REGISTERED as of Tuesday, December 7, 2021. This trademark is owned by Vertex Pharmaceuticals Incorporated. The ALYFTREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
alyftreo

General Information

Serial Number87924232
Word MarkALYFTREO
Filing DateWednesday, May 16, 2018
Status700 - REGISTERED
Status DateTuesday, December 7, 2021
Registration Number6578658
Registration DateTuesday, December 7, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Description of MarkThe mark consists of the word "ALYFTREO" beneath a design consisting of two horizontally oriented curved shapes which are broad at the center and tapered on either end, one on each side of a vertical bar having outwardly curved edges at the top and bottom, and which is narrower at the bottom than at the top, shown with eleven shaded circles of differing sizes.
Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Tuesday, December 7, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 16, 2021CASE RETURNED TO EXAMINATION
Monday, August 16, 2021NOTICE OF ALLOWANCE CANCELLED
Wednesday, July 21, 2021ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, July 20, 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, July 20, 2021ASSIGNED TO PETITION STAFF
Tuesday, July 13, 2021TEAS PETITION TO AMEND BASIS RECEIVED
Saturday, May 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 30, 2021SOU EXTENSION 5 GRANTED
Friday, April 16, 2021SOU EXTENSION 5 FILED
Friday, April 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 16, 2021TEAS EXTENSION RECEIVED
Saturday, October 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 15, 2020SOU EXTENSION 4 GRANTED
Thursday, October 15, 2020SOU EXTENSION 4 FILED
Thursday, October 15, 2020TEAS EXTENSION RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020SOU EXTENSION 3 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 3 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 2 FILED
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019SOU EXTENSION 1 GRANTED
Monday, April 15, 2019SOU EXTENSION 1 FILED
Monday, April 15, 2019TEAS EXTENSION RECEIVED
Friday, November 2, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, October 22, 2018ASSIGNED TO PETITION STAFF
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 17, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2018ASSIGNED TO EXAMINER
Friday, May 25, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 19, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

alyftreo fibrosis cystic treatment preparations pharmaceutical